GLP Ledger is an independent, ad-supported resource that helps people understand what they will actually pay for GLP-1 medications like Zepbound, Wegovy, Mounjaro and Ozempic. We track manufacturer savings-card rules, self-pay programs and coupons — and translate the fine print into plain English.
We are not a pharmacy, a manufacturer, or a telehealth provider. We do not sell medication and we do not provide medical advice. We make money from advertising and, where noted, affiliate partnerships — which never change the price you pay.
Prices and savings terms change frequently. We re-check manufacturer pages, LillyDirect, NovoCare and TrumpRx.gov and date every update. Before publishing, our content is reviewed for accuracy by a licensed reviewer. (Reviewer credentials to be added — this site is a build in progress.)